Literature DB >> 10452165

p53 expression in oral precancer and cancer.

A M Rich1, D Kerdpon, P C Reade.   

Abstract

Expression of the p53 tumour suppressor gene is a frequent finding in human malignancies, including oral cancer, and it has been detected in some potentially malignant lesions. The results of the present project showed that 35 of the 41 (85 per cent) oral mucosal lesions with histological evidence of epithelial dysplasia expressed p53, but the presence or absence of p53 staining could not be used to predict the outcome of potentially malignant oral mucosal lesions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10452165     DOI: 10.1111/j.1834-7819.1999.tb00209.x

Source DB:  PubMed          Journal:  Aust Dent J        ISSN: 0045-0421            Impact factor:   2.291


  5 in total

Review 1.  [Oral cytology: historical development, current status, and perspectives].

Authors:  M Hullmann; T E Reichert; R Dahse; F von Eggeling; H Pistner; H Kosmehl; O Driemel
Journal:  Mund Kiefer Gesichtschir       Date:  2007-01

2.  Genetic alteration of stemness factors and p53 in mouse forestomach by chemical carcinogen-induced carcinogenesis.

Authors:  Kazuyoshi Yamamoto; Hideshi Ishii; Jeong Ho Moon; Naotsugu Haraguchi; Yuichiro Doki; Masaki Mori
Journal:  Oncol Lett       Date:  2012-03-13       Impact factor: 2.967

3.  Oral dysplasia: biomarkers, treatment, and follow-up.

Authors:  Paul Nankivell; Hisham Mehanna
Journal:  Curr Oncol Rep       Date:  2011-04       Impact factor: 5.075

4.  An immunohistochemical study of p53 expressions in oral submucous fibrosis.

Authors:  Sandesh Manjunath; C Girish Himadal; Darshan Devang Divakar; Shaista Haleem; Hussain Ahmed Mohammad Faqeeh; Mohammed Yahya M Alshadidi
Journal:  J Oral Maxillofac Pathol       Date:  2019 May-Aug

5.  Evaluation of Light-Emitting Diodes' Effects on the Expression Level of P53 and EGFR in the Gingival Tissues of Albino Rats.

Authors:  Azhar Ghanim Ahmed; Alaa Hani Raziq
Journal:  Medicina (Kaunas)       Date:  2019-09-18       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.